Mutations in CDKN2A were also more frequently observed in virus-negative tumors (OR = 7.75, 95% CI = 3.59–16.76, q = 9.42e-12), and were significant in HNSCC individually, as noted in a prior study2. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.